Atlas Trials

Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer

Clinical trial NCT06515587 · RECRUITING

Trial details

NCT number
NCT06515587
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
PDAC
Start date
2024-08-01
Primary completion
2026-06-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.